|
Website:
http://www.novartis.com
Phone: +41 61 324 1111 |
Address:
CH-4002 Basel
4002 Basel, |
Company Description
Novartis AG. The Group's principal activity is the development and manufacture of pharmaceuticals and nutritional products. The Group operates through four divisions; Pharmaceuticals, Consumer Health, Sandoz & Vaccines & Diagnostics. Pharmaceuticals Division includes drugs for use in transplantations, central nervous system disorders, cardiovascular, endocrine and respiratory diseases, dermatology, oncology, hematology and rheumatism and bone and hormone replacement therapy. Consumer Health Division includes Generics/OTC and sells copies of prescription medicines no longer under patent protection; medical nutrition and self-medication. Sandoz Division: Manufactures, distributes and sells generic pharmaceutical products and substances no longer subject to patent protection. Vaccines & Diagnostics Division provides innovative vaccines and a range of conventional products to combat viral and bacterial diseases. In 2006, the Group acquired Chiron Corporation & NeuTec Pharma plc. Pharmaceuticals accounted for 63% of 2006 revenues, Consumer Health, 18%, Sandoz, 17% & Vaccines & Diagnostics, 2%
Key People
| Chairman, President & Chief Executive | Dr. Daniel Vasella |
| Chief Financial Officer | Raymund Breu |
| Vice Chairman | Prof. Ulrich Lehner |
| Vice Chairman | Hans-Joerg Rudloff |
| Secretary | Monika Matti |
Related Business Topics
A-Z Novartis Ag Provider Directory
1-9 |
A |
B |
C |
D |
E |
F |
G |
H |
I |
J |
K |
L |
M |
N |
O |
P |
Q |
R |
S |
T |
U |
V |
W |
X |
Y |
Z
N
Novartis AG
Discovers, develops, manufactures and markets arthritis, inflammation, bone, cardiovascular, metabolic, dermatology, hematology, neuroscience, and oncology drugs.
www.novartis.com
Discovers, develops, manufactures and markets arthritis, inflammation, bone, cardiovascular, metabolic, dermatology, hematology, neuroscience, and oncology drugs.
www.novartis.com
Breaking News
Forbes.com - 4 hours ago
OSTEOPOROSIS-FDA/ (UPDATE 2):UPDATE 2- WASHINGTON (Reuters) - Clinical trial data from four drugmakers shows no overall risk of heart problems in patients taking certain drugs to treat osteoporosis, the Food and Drug Administration said Wednesday. The ...
Reuters - 5 hours ago
WASHINGTON, Nov 12 (Reuters) - Clinical trial data from four drugmakers shows no overall risk of heart problems in patients taking certain drugs to treat osteoporosis, the U.S. Food and Drug Administration said on Wednesday. The agency reviewed studies ...
Reuters India - 5 hours ago
WASHINGTON, Nov 12 (Reuters) - Clinical trial data from four drugmakers shows no overall risk of heart problems in patients taking certain drugs to treat osteoporosis, the U.S. Food and Drug Administration said on Wednesday. The agency reviewed studies ...
Forbes.com - 8 hours ago
OSTEOPOROSIS-FDA/ (UPDATE 1):UPDATE 1- WASHINGTON (Reuters) - Clinical trial data from four drugmakers shows no overall risk of heart problems in patients taking certain drugs to treat osteoporosis, the Food and Drug Administration said Wednesday. The ...
Reuters - 10 hours ago
WASHINGTON (Reuters) - A review of clinical trial data from four drugmakers shows no overall risk of heart problems in patients taking drugs to treat osteoporosis, the U.S. Food and Drug Administration said on Wednesday. The agency reviewed studies on ...
Pharmaceutical Industry
Securely Store Pharmaceutical Contracts Online for Easy Access
www.Selectica.com
Securely Store Pharmaceutical Contracts Online for Easy Access
www.Selectica.com
Pfizer Prescription Help
Annual income under $34k to qualify Pfizer Connection to Care Program
www.myrxadvocate.com
Annual income under $34k to qualify Pfizer Connection to Care Program
www.myrxadvocate.com
Pharmaceutical Companies
Daily Drug Pipeline Updates Pharmaceutical Company Profiles
www.BioPharmInsight.com
Daily Drug Pipeline Updates Pharmaceutical Company Profiles
www.BioPharmInsight.com



